Education
PhD (Pharmacology), College of Medicine, University of Florida, 1995
MS (Neuroscience), Shanxi Medical University, Taiyuan, China, 1985
BS (Medicine), Shanxi Medical University, Taiyuan, China, 1982
Courses
Anatomy (PHAR 110g)
Anatomy Lab ((PHAR 112G)
Physiology and Pathophysiology I (PHAR 113G)
Integrated Therapeutics I (PHAR 211G)
Integrated Therapeutics II (PHAR 212G)
Integrated Therapeutics III (PHAR 213G)
Research
Dr. Wang is interested in research and development of new medicines that affect the
cardiovascular system, metabolism homeostasis and central nervous system. Previously,
Dr. Wang’s research had been funded by NIEHS/NIH, NIH and CV Therapeutics, Inc (California).
At PCOM, Dr. Wang’s research has been funded by intramural research programs such
as the CCDA center and the CRSO office.
Awards
Researcher of the Year, College of Pharmacy (USC), 2005
NIH Merit Award, for helping to publish CEHP journal by NIEHS/NIH, 2001
Transition to Independent Position Award, NIEHS/NIH, 2000
2000 Fare Award, National Institute of Health, 1999
Research Fellowship, American Heart Association (FL Affiliate), 1995
Outstanding Student of University of Florida, 1994
Procter & Gamble Professional Opportunity Award, Am. Physiol. Society, 1993
Elite Young Researcher Award, Chinese Physiological Society, 1988
Memberships
- American Heart Association/American Stroke Association - Council on Basic Cardiovascular
Sciences/Council on High Blood Pressure Research
- American Association of Colleges of Pharmacy (AACP)
- PCOM Student Academic Progress & Policy Committee
- PCOM Appointment, Promotion and Tenure committee
- Curriculum Committee of PCOM School of Pharmacy
- AP&S committee of PCOM School of Pharmacy
Grants
NIEHS/NIH
Funding period: 2001-2004
Project title: Effects of Dioxins (TCDD) on Cardiac ion Channels.
Principal Investigator: Desuo Wang
Budget: $324,000
NIEHS/NIH
Funding period: 2005-2007
Project title: Ambient particulate matters poison cardiac ion channels.
Principal Investigator: Desuo Wang
Budget: $430,000
University of South Carolina
Cancer Complementary and Alternative Medicine Center at University of South Carolina
Funding period: 2004-2005
Co-investigator: Desuo Wang (PI for project#4 with an independent budget of $40,000)
Budget: $250,000
CV Therapeutics, Inc (California)
Funding period: 2008-2009
Project title: Mechanism of cardiac protective effect of inhibitors of late sodium
current.
Principal Investigator: Desuo Wang
Budget: $195,000
CCDA (PCOM)
Funding period: 2010-2011
Project title: Dually Targeting L-type Ca2+ Channel and Type 4 Phosphodiesterase for
Treatment of Obesity
Principal Investigator: Desuo Wang
Budget: $8,000
CCDA (PCOM)
Funding period: 2012-2013
Project title: Angiotensin II and glutamate additively or synergistically disrupt
the intracellular Ca2+ homeostasis of astroglia
Principal Investigator: Desuo Wang
Budget: $9,600